Found 2247 matching trials
EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC) PHASE1 Primary trial objective in this single arm trial is to assess the safety an...
Show More Location
Department of Thoracic Oncology, Netherlands Cancer Instiute - Antoni van Leeuwenhoek Hospital
Learn More & Join Trial
Efficacy Response Duration and Toxicity of Rituximab, Fludarabine, and Cyclophosphamide (RFC) as 1st Line Treatment and Rituximab (R) in Maintenance Treatment in Follicular Non Hodgkin (FNH) Lymphoma PHASE4 The purpose of this study is to determine whether the rituximab administrat...
Show More Location
Hospital Infanta Cristina
Learn More & Join Trial
Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy PHASE2 This study is a multicenter, prospective, randomized phase II trial aimed a...
Show More Location
Zhejiang Cancer Hospital
Learn More & Join Trial
A Combination Study of CAR-T Therapy in r/r B-NHL PHASE2 In registry studies of CAR-T products that have been marketed globally, pat...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
Randomized Clinical Trial of Endovascular Treatment for Progressive Stroke With Vertebrobasilar Artery Occlusion NA This multicenter, prospective, open-label randomized controlled trial with ...
Show More Location
Beijing Tiantan Hospital, Capital Medical University
Learn More & Join Trial
ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs PHASE2 The goal of this prospective study is to explore the safety and preliminary...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Proactive Temperature Management in CRS-HIPEC for Prevention of Delirium NA This randomized controlled trial evaluates the efficacy of a proactive Goal...
Show More Location
Aerospace Center Hospital
Learn More & Join Trial
Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy PHASE2 RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
Study of Osimertinib+Bevacizumab+Chemotherapy for EGFR+ Advanced Non-Small Cell Lung Cancer With Concurrent Mutations PHASE2 This is a single-center, open-label, phase I clinical trial aimed to evalua...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
Cadonilimab Plus CapeOX as First-Line Treatment for Advanced GC/GEJC With High TMEscore PHASE2 This is a single-arm, open-label, multi-center clinical study to evaluate t...
Show More Location
Nanfang Hospital, Southern Medical University
Learn More & Join Trial